Possibilities of IVF in native cycle
Authors:
V. Paseková; T. Mardešić
Authors place of work:
Sanatorium Pronatal, Praha, vedoucí lékař doc. MUDr. T. Mardešić, CSc.
Published in the journal:
Ceska Gynekol 2012; 77(2): 175-178
Category:
Původní práce
Summary
Objective:
To evaluate the benefits and possibilities of the native cycle and / or minimal stimulation with subsequent use of methods of in-vitro fertilization.
Type of study:
Overview.
Setting:
Pronatal, sro, Prague.
Methods and results:
Native or modified cycles with minimal stimulation now experiencing a renaissance, mainly due to the onset of antagonists of gonadoliberines. Except for the standard controlled ovarian hyperstimulation protocols we use for acquiring of oocyte other different methods – free native cycles, ovulation induction with antiestrogens and / or adding the minimum doses of gonadotropins. Concomitant use of antagonists prevents premature peak of luteinizing hormone, that was previously characteristic for these procedures. Native cycles we can use virtually for all the factors of infertility. Pregnancy rate per cycle is about 17%, but the cumulative pregnancy rate after three consecutive cycles reaches over 30%.
Conclusion:
Native cycle and its current modifications and subsequent in vitro fertilization offers the benefit of minimal consumption of drugs and the practical absence of side effects. It is characterized by short duration, lower price and the possibility of repetition each month. Virtually eliminates the occurrence of multiple pregnancies. Its efficiency is however limited and is characterized by a high number of cancellations. The cumulative pregnancy rate per embryo transfer is comparable with pregnancy rate of conventional stimulation protocols.
Key words:
native cycle, minimal stimulation, in-vitro fertilization.
Zdroje
1. Baroni, E., Ubaldi, F., Rienzi, L., et al. Hopes and facts about mild ovarian stimulation. Reprod Biomed Online, 2007, 14(6), p. 675–681.
2. Bensdorp, AJ., Slappendel, E., Koks, C., et al. The INeS study: prevention of multiple pregnancies: a randomised controlled trial comparing IUI COH versus IVF e SET versus MNC IVF in couples with unexplained or mild male subfertility. BMC Womens Health, 2009, 18, p. 35.
3. Edwards, RG. IVF, IVM, natural cycle IVF, minimal stimulation IVF – time for a rethink. Reprod Biomed Online, 2007, 15(1), p. 106–119.
4. Weissman, A., Howles, CM. Treatment strategies in assisted reproduction for the low responder patient. In: Gardner, DK., Weissman, A., Colin, MH., Shoham, Z. Textbook of Assisted Reproductive Technologies. Laboratory and Clinical Perspectives. 3rd Ed. Informa Healthcare, UK, London, 2009.
5. Paseková, V., Mardešić, T. , Vobořil, J., et al. Přenos jednoho embrya (single embryo transfer): možnosti a limity. Čes Gynek, 2011, 76, 5, s. 390–400.
6. Pelinck, MJ., Vogel, NEA., Hoek, A., et al. Minimal stimulation IVF with late folicular phase administration of the GnRH antagonist cetrorelix and concomitant substitution with recombinant FSH: a pilot study. Hum Reprod, 2005, 20, p. 642–648.
7. Rongieres-Bertrand, C., Olivennes, F., Righini, C. Revival of the natural cycles in in vitro fertilization with the use of a new gonadotrophin – releasing hormone antagonist /cetrorelix/: a pilot study with minimal stimulation. Hum Reprod, 1999, 14, p. 683–688.
8. Ubaldi, F., Rienzi, L., Baroni, E., et al. Hopes and facts about mild ovarian stimulation. Reprod Biomed Online, 2007, 14(6), p. 675–681.
Štítky
Dětská gynekologie Gynekologie a porodnictví Reprodukční medicínaČlánek vyšel v časopise
Česká gynekologie
![Číslo 2](https://www.prolekare.cz/media/cache/resolve/journal_issue/media/image_pdf/7a9c6c24cb265c06c3affaa87cbb4ba1.jpeg)
2012 Číslo 2
- Horní limit denní dávky vitaminu D: Jaké množství je ještě bezpečné?
- Moje zkušenosti s Magnosolvem podávaným pacientům jako profylaxe migrény a u pacientů s diagnostikovanou spazmofilní tetanií i při normomagnezémii - MUDr. Dana Pecharová, neurolog
- Magnosolv a jeho využití v neurologii
- Nedostatek hořčíku se projevuje u stále více lidí
- Prevence opakovaných infekcí močových cest s využitím přípravku Uro-Vaxom
Nejčtenější v tomto čísle
- Triple negativní karcinom prsu – prognosticky vysoce závažná skupina mamárních malignit
- Možnosti IVF v nativním cyklu
- Uroinfekce v graviditě – kdy léčit, jak léčit a čím léčit
- Vedení porodu po předchozím císařském řezu, analýza výsledků z let 2007–2010